COMP <GO>
ARGX vs RVMD // GROSS PROFIT MARGIN
argenx SE (NASDAQ) VS. Revolution Medicines Inc. (NASDAQ) • 15-METRIC TALLY: ARGX 7
— RVMD 2
■ METRIC PARITY
LAST: $897.85 (+0.68%) • MKT CAP: $55.72B
gross-margins
—
LAST: $190.27 (+0.82%) • MKT CAP: $40.78B
gross-margins
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ARGX VS. RVMD)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ARGX | RVMD | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin ACTIVE | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 9.90% | -28.60% | +38.50 | ARGX | /roic <GO> |
| EV/EBITDA & P/E Valuation | 21.0x | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 2.21% | -2.24% | +4.45 | ARGX | /fcf-yield <GO> |
| Operating Margin | 13.90% | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | 10.90% | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | 18.70% | 15.40% | +3.30 | ARGX | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.74 | 26.00 | -22.26 | RVMD | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 5/9 | +3.00 | ARGX | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 51.7 | 47.8 | +3.90 | ARGX | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.02 | 1.07 | -0.05 | RVMD | /macro-sensitivity <GO> |
| Forward P/E Multiple | 27.6x | 34.0x | -6.40 | ARGX | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $55.72B | $40.78B | $14.94B | ARGX | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ARGX REV | RVMD REV | ARGX GROSS % | RVMD GROSS % | ARGX FCF | RVMD FCF |
|---|---|---|---|---|---|---|
| FY 2025 | — | $0 | — | — | — | -$913.7M |
| FY 2024 | — | $0 | — | — | — | -$567.7M |
| FY 2023 | — | $11.6M | — | — | — | -$351.1M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ARGX // BETA 1.02
RVMD // BETA 1.07